Detalhe da pesquisa
1.
Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?
Int J Mol Sci
; 24(24)2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38139339
2.
Rationale for combined therapies in severe-to-critical COVID-19 patients.
Front Immunol
; 14: 1232472, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37767093
3.
Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial).
Trials
; 22(1): 595, 2021 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34488845
4.
Mesenchymal Stromal Cell-Based Therapies as Promising Treatments for Muscle Regeneration After Snakebite Envenoming.
Front Immunol
; 11: 609961, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33633730
5.
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study.
EClinicalMedicine
; 25: 100454, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32838232
6.
On-line analysis of gap junctions reveals more efficient electrical than dye coupling between islet cells.
Am J Physiol Endocrinol Metab
; 284(5): E980-7, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12517739